Analyst Recommendations
1.31 -0.02(-1.14%)07/03/2024
CytomX Therapeutics Inc (CTMX)
CytomX Therapeutics Inc (CTMX)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Market Perform | 3 |
Neutral | 2 |
Buy | 1 |
Outperform | 1 |
Overweight | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades